Agios Pharmaceuticals Inc. buy Truist Financial Co.
Start price
24.11.25
/
50%
€23.00
Target price
24.11.26
-
Performance (%)
29.57%
Price
11.08.26
€29.80
Summary
This prediction is currently active. The prediction currently has a performance of 29.57%. This prediction currently runs until 24.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Agios Pharmaceuticals Inc. | 12.030% | 12.030% |
| iShares Core DAX® | 0,18 % | 5,07 % |
| iShares Nasdaq 100 | -0,77 % | -2,08 % |
| iShares Nikkei 225® | 0,73 % | -3,35 % |
| iShares S&P 500 | -0,17 % | 0,90 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.00
31.07.26
31.07.26
€33.88
31.07.27
31.07.27
7.69%
11.08.26
11.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€33.60
07.07.26
07.07.26
€35.85
07.07.27
07.07.27
-11.31%
11.08.26
11.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€24.00
30.04.26
30.04.26
€30.85
30.04.27
30.04.27
24.17%
11.08.26
11.08.26
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€23.80
24.12.25
24.12.25
€32.19
24.12.26
24.12.26
25.21%
11.08.26
11.08.26